DR. JACK A. STROH, M.D.

Plain English
This study focused on how a protein called Drp1 is involved in a type of cell death known as ferroptosis, which is caused by excessive damage to fats in cells. Researchers found that when ferroptosis is triggered, Drp1 helps break down mitochondria (the energy powerhouses of cells), speeding up cell death. Specifically, they observed that activating Drp1 led to faster cell death in this process, which could have important implications for treating diseases where ferroptosis plays a role, like certain types of cancer. Who this helps: Patients with diseases linked to ferroptosis, particularly cancer patients.

Plain English
This study looked at a specific type of cell death called ferroptosis and how it affects communication with the immune system. Researchers found that when cells undergo ferroptosis, they release various proteins and other molecules that can activate immune cells, particularly macrophages. For instance, macrophages exposed to these secretions increased their production of inflammatory signals, suggesting that ferroptosis plays a role in regulating inflammation. Who this helps: This information helps doctors and researchers understand how to manage inflammation in diseases linked to ferroptosis.

Plain English
This study examined how a cancer drug called ibrutinib affects a type of blood cancer known as diffuse large B-cell lymphoma (DLBCL), particularly its more aggressive forms. Researchers discovered that ibrutinib enhances a specific type of cell death called ferroptosis, which occurs when cells accumulate harmful lipids in the presence of iron. They found that when DLBCL cells were treated with ibrutinib and a specific inhibitor of a protective protein (GPX4), it led to increased cell death, showing a promising new approach for treatment. Who this helps: This benefits patients with diffuse large B-cell lymphoma, particularly those who have high-risk subtypes that often resist current therapies.

Plain English
This study explored how the absence of a protein called caspase 8 affects small cell lung cancer (SCLC) in mice. Researchers found that without caspase 8, the cancer cells became more aggressive and behaved like immature nerve cells, leading to more inflammation and metastasis. Specifically, the loss of caspase 8 increased the recruitment of certain immune cells (Tregs) that help the cancer spread. Who this helps: This research benefits patients with small cell lung cancer by revealing potential new targets for treatment.

Plain English
This study examined how two types of clinical decision support (CDS) systems can improve the identification of patients at risk for suicide. Researchers found that using an interruptive CDS—an alert that pops up on the screen—increased the number of doctors deciding to assess a patient's suicide risk to 42%, compared to just 4% with a noninterruptive version. This difference is significant because it highlights an effective way to enhance suicide screenings in medical settings. Who this helps: This benefits patients by ensuring that doctors more frequently assess suicide risk, potentially leading to earlier interventions and better outcomes.

Plain English
Researchers studied how to improve medication management for patients with Parkinson disease in a hospital setting. They found that when pharmacists conducted patients' medication histories, the accuracy of prescribed medications improved significantly, matching home regimens 89% of the time compared to only 40% when pharmacists were not involved. As a result, there were fewer falls and readmissions, with falls decreasing from 5% to about 4% and readmissions dropping from 10.81% to 4.53%. Who this helps: This helps patients with Parkinson disease by ensuring they receive more accurate medication while hospitalized.

Plain English
This study looked at how well a treatment called tixagevimab/cilgavimab (TIX/CGB) protects patients with blood cancers from catching COVID-19 before they are exposed to it. Researchers found that 32% of patients receiving TIX/CGB still got COVID-19, which was similar to the 36% infection rate in patients who did not get the treatment. This matters because it shows that TIX/CGB can be an effective preventive measure for patients who have not yet been infected, helping to safeguard those most at risk during the pandemic. Who this helps: This helps patients with hematologic malignancies.

Plain English
This study examined how a new digital tool could help doctors identify patients at high risk for suicide in outpatient neurology clinics. Researchers tested two different approaches: one that interrupted doctors during patient visits and one that did not. The interruptive tool resulted in significantly more decisions to screen for suicidal thoughts—42% compared to just 4% with the non-interruptive tool—showing that it was much more effective at prompting screenings. Who this helps: This benefits patients at risk for suicide by increasing the chances of early detection and intervention.

Plain English
This study examined how a specific mutant form of the KRAS gene, which is linked to aggressive cancers, helps cancer cells survive by resisting a type of cell death called ferroptosis. Researchers found that KRAS-mutated cells have higher levels of a protein called FSP1, which protects them from ferroptosis and allows the tumors to grow; for instance, FSP1 was found to promote tumor growth in lab conditions. This matters because targeting both ferroptosis and FSP1 could lead to more effective treatments for cancers associated with KRAS mutations. Who this helps: Patients with KRAS-mutant cancers.

Plain English
This study looked at a protein called SLF2 and its role in B-cell lymphoma, a type of blood cancer. Researchers found that when SLF2 is absent, DNA repair processes in lymphoma cells become faulty, leading to increased DNA damage and cancer growth. They also discovered that using drugs that target both the faulty DNA repair and another process related to SLF2 could be an effective treatment strategy, especially for patients with severe forms of this cancer. Who this helps: This helps patients with aggressive B-cell lymphoma and their doctors in finding better treatment options.

Plain English
This study looked at how the levels of a protein called MCT1 in multiple myeloma patients can predict their response to a drug called lenalidomide. Researchers found that patients with high MCT1 levels had shorter periods without disease progression (about 32 months compared to 48 months for those with low MCT1) and shorter overall survival (nearly 76 months compared to not reached for low MCT1). This is significant because it helps doctors identify which patients might not benefit from lenalidomide, allowing for better treatment decisions. Who this helps: Patients with multiple myeloma.

Plain English
This study looked at a new imaging technique using a substance called [F]-FACBC to see how well it can detect multiple myeloma, a type of blood cancer. The researchers found that [F]-FACBC worked better than another imaging agent, allowing them to spot cancer lesions with higher accuracy in a patient, showing an uptake rate of 8.0 compared to a normal rate of 5.7 in healthy bone marrow. This matters because it could help doctors better identify and assess the extent of multiple myeloma in patients, leading to more effective treatment plans. Who this helps: Patients with multiple myeloma.

Plain English
This study looked at problems that can happen after patients have surgery to create artificial openings in the body called stomas, which can be temporary or permanent. Researchers found that complications occur frequently, leading many patients to visit emergency rooms for help. Understanding these issues is important because emergency doctors need to be aware of how to treat patients with stomas, ensuring they receive proper care. Who this helps: This helps patients with stomas and the emergency doctors who treat them.

Plain English
This study focused on improving the involvement of palliative care (PPC) teams for children with cancer, aiming to increase the time patients received care before death. Researchers successfully extended the median days from the PPC consultation to death from 13.5 days to 159.5 days and increased the percentage of patients receiving PPC more than 30 days before dying from 43% to 100%. This improvement mattered because better access to palliative care can enhance the quality of life for these young patients and ensure their treatment aligns more closely with their goals. Who this helps: This benefits pediatric patients with cancer and their families.

Plain English
This study focused on a type of cell death called ferroptosis, which is caused by iron and leads to the breakdown of cell membranes. Researchers found that an increase in calcium levels inside cells is a key sign of ferroptosis and that this increase helps trigger a repair process that can slow down cell death. Specifically, they noticed that certain protective mechanisms can delay the damage caused by ferroptosis. Who this helps: This helps doctors and researchers understand how to better manage conditions related to cell death, like certain cancers and neurodegenerative diseases.

Plain English
This study looked at how a specific protein called cereblon (CRBN), which is the target of certain cancer drugs, affects the quality control processes for proteins that span cell membranes in multiple myeloma, a type of blood cancer. Researchers found that CRBN helps another protein (HSP90) do its job, but when treated with immunomodulatory drugs (IMiDs), this process is disrupted. They discovered that a protein called LAT1/CD98hc plays a key role in how IMiDs work and suggested it could be a useful target for new treatments and tests. Who this helps: Patients with multiple myeloma.

Plain English
This study examined how different types of small cell lung cancer (SCLC) respond to cell death processes, specifically focusing on a type called ferroptosis. Researchers found that non-neuroendocrine SCLC cells are vulnerable to ferroptosis, while neuroendocrine SCLC cells resist it but rely on another survival pathway. By combining treatments, they effectively killed both types of cancer cells in lab models, which could significantly improve survival rates for certain patients. Who this helps: This benefits patients with small cell lung cancer, especially those with different subtypes of the disease.

Plain English
This study examined patients who tested positive for the SARS-CoV-2 virus more than 70 days apart to determine if they were experiencing a new infection or if the virus was still lingering in their system. Out of 11 patients, 7 showed signs of re-infection while 4 had prolonged RNA shedding, meaning the virus was still present without being capable of causing a new infection. Understanding the difference is important for better managing patient care and informing treatment decisions. Who this helps: This helps doctors in accurately diagnosing and treating COVID-19 patients.

Plain English
The study examined how a drug called dynasore protects cells from a type of cell death known as ferroptosis, which is driven by iron and harmful molecules called reactive oxygen species (ROS). The researchers found that dynasore can effectively prevent ferroptosis in lung cancer and nerve cell lines by inhibiting both the uptake of iron and the production of ROS in the cells, which are critical for this type of cell death. Notably, dynasore was shown to be a more effective antioxidant than another common treatment, blocking ferroptosis significantly better. Who this helps: This benefits patients with conditions involving iron-related cell death, such as cancer and neurodegenerative diseases.

Plain English
This study focused on a new and eco-friendly way to produce ettringite, a mineral valuable in making cement and other construction materials. Researchers found that using a two-step process improved the formation of ettringite compared to traditional methods, leading to a better reaction and smaller particle sizes. This matters because it not only enhances the efficiency of producing a key component of cement but also supports sustainability in construction materials. Who this helps: This benefits manufacturers and builders looking for greener and more effective cement production methods.

Plain English
This study focuses on a new, faster method to create ettringite, an important mineral used in cement and various industrial applications. By changing the process to involve two steps instead of one, researchers improved the production efficiency significantly, achieving a conversion rate of 94% compared to just 34% with the previous method. This matters because it provides a more environmentally friendly way to produce ettringite with less waste and lower emissions. Who this helps: This benefits manufacturers in the cement, ceramic, and paper industries.

Plain English
This study looked at how different additives and sulfate carriers affect the hydration process of Portland cement, which is essential for creating strong concrete. Researchers used various techniques to see that these factors significantly change how quickly and effectively cement hydrates, revealing different structures over time. For instance, they could measure specific amounts of different components in the cement paste to understand these changes better. Who this helps: This research helps engineers and builders develop stronger and more durable cement-based materials.

Plain English
Researchers created a training module on palliative care for newborns because many pediatric hospital doctors wanted more education in this area. After testing the module, participants scored an average of 96% on a posttest, up from 90% on a pretest, showing that the training was effective. This matters because it improves the care doctors can provide to newborns with serious health issues. Who this helps: This helps pediatric hospitalists and healthcare providers working with newborns.

Plain English
This study looked at deep brain stimulation (DBS), a treatment for movement disorders, to understand what increases the risk of infection after surgery. Out of 447 patients, 26 (about 5.82%) developed an infection after the procedure, with 9 (2.01%) getting an infection within the first 30 days. Key factors linked to higher infection rates included the surgeon's experience, scalp erosion, longer surgical times, and the number of people present in the operating room, which can help improve safety during these surgeries. Who this helps: This information benefits patients undergoing DBS and their doctors by reducing the risk of infections.

Plain English
This study focused on developing methods to understand how certain chemical groups in drugs can permanently attach to proteins, which could improve their effectiveness. Researchers measured how these groups reacted with a naturally occurring molecule in the body called glutathione and discovered various reactivity patterns. They created a computer-based method to predict how reactive these chemical groups are, which can help design safer and more effective drugs. Who this helps: This benefits drug developers and researchers looking to create safer medications for patients.

Plain English
This research studied a new compound called 6β-(hydroxymethyl)penicillanic acid sulfone, which blocks certain enzymes (β-lactamases) that can make antibiotics less effective. The findings showed that this compound was highly effective at inhibiting two important β-lactamases—TEM-1 and PDC-3—requiring only 12 nM and 180 nM concentrations, respectively, to stop half of their activity. This is significant because it enhances the effectiveness of antibiotics like ampicillin against infections caused by resistant bacteria. Who this helps: This helps patients with serious infections, especially those caused by antibiotic-resistant bacteria.

Plain English
This study looked at how the flexibility of eye lenses decreases with age, which is mainly responsible for difficulties in focusing, known as presbyopia. Researchers tested 36 donated human eye lenses and found that using a specific laser treatment on pairs of lenses significantly improved their flexibility: the treated lenses showed a greater polar strain difference compared to untreated ones, with results showing a highly significant improvement (P = 0.001 and P = 0.004). This is important because it suggests a potential method to restore focusing ability in older adults. Who this helps: Older patients experiencing difficulty focusing on close objects.

Plain English
This study examined how the heart functions during and after intense upper-body exercises in two groups: 25 healthy men and 22 men who had a heart attack. Both groups showed an increase in heart rate during exercise, but the heart attack survivors had lower blood flow and heart function during exertion and a greater increase in heart output during recovery. This research reveals that measuring heart function during such exercises can be an important tool for assessing heart health, especially after a heart attack. Who this helps: This helps doctors understand heart function in patients with a history of heart disease.

Plain English
Researchers studied the effects of taking verapamil, a medication, twice a day on 21 adults with mild to moderate high blood pressure. They found that after four weeks, most participants had a significant drop in their blood pressure, with 12 out of 21 patients seeing a decrease of 10 mm Hg or more. This is important because it shows that taking verapamil is both safe and effective for managing high blood pressure, and monitoring the drug levels in patients can help tailor their treatment. Who this helps: This helps patients with high blood pressure as well as their doctors in managing their treatment more effectively.

Plain English
This study compared two medications, diltiazem and nifedipine, in 10 patients suffering from chest pain (angina) and high blood pressure. Both drugs were effective: patients experienced fewer episodes of angina and used less nitroglycerin, and their exercise tolerance improved significantly. Blood pressure also decreased, with diltiazem reducing rest heart rates more than nifedipine. Who this helps: This research benefits patients with angina and hypertension.